Expression of CD44 isoforms in human skin cancer

被引:27
|
作者
Simon, JC
Heider, KH
Dietrich, A
Wutting, C
Schopf, E
Adolf, GR
Ponta, H
Herrlich, P
机构
[1] BENDER & CO GMBH,VIENNA,AUSTRIA
[2] FORSCHUNGSZENTRUM KARLSRUHE,INST GENET,KARLSRUHE,GERMANY
关键词
CD44; isoforms; basal cell carcinoma; squamous cell carcinoma; malignant melanoma;
D O I
10.1016/0959-8049(96)00196-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In animal models, isoforms of CD44 (CD44v) containing sequences encoded by one or several of ten different exons (v1-v10) contribute to tumour metastasis. In certain human cancers, CD44v6 expression is associated with poor prognosis. This gaper examines CD44v expression in skin carcinogenesis and skin cancer metastasis. CD44v expression was studied in basal cell carcinoma (BCC), squamous cell carcinoma (SCC), primary malignant melanoma (MMM), metastases of IMM (MMM), benign melanocytic naevi (BMN) and normal skin (NS) by immunohistochemistry and reverse transcript polymerase chain reaction (RT-PCR). BCC, SCC and NS expressed several CD44v including v6, albeit in different distributions and intensities. PMM, MMM and BMN expressed isoforms containing v7/8 and v10, but failed to express epitopes encoded by v5 or v6. Thus, different CD44 isoforms are found in human skin cancers and ape modulated during carcinogenesis. However, we did not observe a correlation of CD44v6 expression with metastatic potential. Copyright (C) 1996 Published by Elsevier Science Ltd
引用
收藏
页码:1394 / 1400
页数:7
相关论文
共 50 条
  • [41] Modulation of isoforms of CD44 adhesion molecule in a murine model of gut-ischemia-reperfusion.
    Cabrera, PV
    Blanco, G
    Argibay, P
    Hajos, SE
    MEDICINA-BUENOS AIRES, 2000, 60 (06) : 940 - 946
  • [42] CD44 Expression Is Predictive of Poor Prognosis in Pharyngolaryngeal Cancer: Systematic Review and Meta-Analysis
    Chai, Liang
    Liu, Hongyan
    Zhang, Zhili
    Wang, Feng
    Wang, Qingying
    Zhou, Shuihong
    Wang, Shenqing
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2014, 232 (01): : 9 - 19
  • [43] CD44 affects the expression level of FOS-like antigen 1 in cervical cancer tissues
    Xiao, Songshu
    Zhou, Yanhong
    Jiang, Jianfa
    Yuan, Le
    Xue, Min
    MOLECULAR MEDICINE REPORTS, 2014, 9 (05) : 1667 - 1674
  • [44] CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression
    Zhu, Hanzhang
    Zhou, Weijiang
    Wan, Yafeng
    Lu, Jun
    Ge, Ke
    Jia, Changku
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [45] Hyaluronan, CD44 and versican in epidermal keratinocyte tumours
    Karvinen, S
    Kosma, VM
    Tammi, MI
    Tammi, R
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (01) : 86 - 94
  • [46] Expression of CD44 isoforms in squamous cell carcinoma of the border of the tongue: A correlation with histological grade, pattern of stromal invasion, and cell differentiation
    Fonseca, I
    Pereira, T
    Rosa-Santos, J
    Soares, J
    JOURNAL OF SURGICAL ONCOLOGY, 2001, 76 (02) : 115 - 120
  • [47] The CD44 variant isoforms CD44v6 and CD44v7 are expressed by distinct leukocyte subpopulations and exert non-overlapping functional activities
    Seiter, S
    Schmidt, DS
    Zöller, M
    INTERNATIONAL IMMUNOLOGY, 2000, 12 (01) : 37 - 49
  • [48] Expression of CD44 isoforms on isolated bone marrow plasma cells and peripheral CD19+ B cells of patients with multiple myeloma and healthy individuals
    Schuster-Kolbe, J
    Ludwig, H
    Adolf, GR
    Heider, KH
    LEUKEMIA & LYMPHOMA, 1999, 34 (1-2) : 95 - 103
  • [49] The role of CD44 in epithelial-mesenchymal transition and cancer development
    Xu, Hanxiao
    Tian, Yijun
    Yuan, Xun
    Wu, Hua
    Liu, Qian
    Pestell, Richard G.
    Wu, Kongming
    ONCOTARGETS AND THERAPY, 2015, 8 : 3783 - 3792
  • [50] Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer
    Karousou, Evgenia
    Misra, Suniti
    Ghatak, Shibnath
    Dobra, Katalin
    Goette, Martin
    Vigetti, Davide
    Passi, Alberto
    Karamanos, Nikos K.
    Skandalis, Spyros S.
    MATRIX BIOLOGY, 2017, 59 : 3 - 22